Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
29
Number of overlapping holdings
51.8%
% of HELX's 62 holdings also in WDNA
33.0%
% of WDNA's 91 holdings also in HELX
Overlap by Weight
Sector Drift (HELX minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HELX |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 3.1% | 2.2% | 2.2% |
|
ELI LILLY & CO | 4.2% | 2.1% | 2.1% |
|
SAREPTA THERAPEUTICS INC | 1.8% | 1.7% | 1.7% |
|
VERTEX PHARMACEUTICALS INC | 5.6% | 1.6% | 1.6% |
|
TWIST BIOSCIENCE CORP. | 1.5% | 4.3% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
HELX Overweight Relative to WDNA
|
MEDPACE HOLDINGS, INC. | 6.4% |
|
KRYSTAL BIOTECH, INC. | 5.0% |
|
VERTEX PHARMACEUTICALS INC | 4.0% |
|
REGENERON PHARMACEUTICALS | 3.8% |
|
DANAHER CORP | 3.7% |
|
THERMO FISHER SCIENTIFIC INC | 3.7% |
 |
SAMSUNG BIOLOGICS CO., LTD. | 3.3% |
|
BRUKER CORP | 2.4% |
|
CHARLES RIVER LABORATORIES | 2.2% |
|
ELI LILLY & CO | 2.2% |
HELX Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -2.8% |
 |
NOVOZYMES A/S-B SHARES | -2.7% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
GERON CORP | -2.5% |
|
AGIOS PHARMACEUTICALS INC | -2.4% |
|
FATE THERAPEUTICS INC | -2.2% |
|
VERICEL CORPORATION | -2.1% |
|
IOVANCE BIOTHERAPEUTICS INC | -1.7% |
|
MYRIAD GENETICS INC | -1.4% |
|
AMGEN INC | -1.4% |